[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

The 2011 Leading Life Science Intermediates Companies R&D Expenditures and Major Programs

October 2010 | 32 pages | ID: L023F845D5AEN
Venture Planning Group

US$ 1,480.00 US$ 1,850.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global PDF: US$ 3,900.00

For each company, the report provides:
  • Estimated R&D budget.
  • Research facilities and staff.
  • New technologies, products and applications in development.
The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia.

Contains 32 pages


More Publications